Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. This study was designed to determine whether the clinical responses (healing, or...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hadighi, Ramtin, Mohebali, Mehdi, Boucher, Patrick, Hajjaran, Homa, Khamesipour, Ali, Ouellette, Marc
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2006
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1435779/
https://ncbi.nlm.nih.gov/pubmed/16605301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0030162
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים